BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

January 30, 2024

https://www.globenewswire.com/news-release/2024/01/31/2820685/0/en/BriaCell-Therapeutics-Corp-Announces-Results-of-Shareholder-Meeting.html

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq:BCTX, BCTXW) (TSX:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce the results of its annual general meeting of shareholders of the Company (the “Shareholders”) for the year ended July 31, 2023 held on January 30, 2024 (the “Meeting”). A total of 5,375,071 common shares of the Company (the “Common Shares”) were voted, representing 33.63% of the Company’s issued and outstanding Common Shares.

Read more at globenewswire.com

Related news for (BCTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.